4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-060790
Chief R&D Officer acquired 40,150 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Zalevsky Jonathan · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-12 | Grant or award : show line 1 in the form | +40,150 | 331,847 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-12 | Grant or award : show line 2 in the form Stock Option | +71,550 | 71,550 | D |
| 2019-12-12 | Grant or award : show line 3 in the form Stock Option | +20,100 | 20,100 | D |
Loading xslF345X03/doc4.xml…